Hormone therapy and the risks of breast and endometrial cancers

Citations

1. Canadian Cancer Society (2005). Breast cancer stats. Available online: http://www.cancer.ca/ccs/internet/standard/0,3182,3172_14435_371399_langId-en,00.html.

2. American College of Obstetricians and Gynecologists Women's Health Care Physicians (2004). Breast cancer. Obstetrics and Gynecology, 104(4, Suppl): 11S–16S.

3. Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382): 419–427.

4. Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 291(14): 1701–1712.

5. Mishell DR (2001). Menopause. In MA Stenchever et al., eds., Comprehensive Gynecology, 4th ed., pp. 1217–1258. St. Louis: Mosby.

6. Rossouw JE, et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321–333.

Author:	Kathe Gallagher, MSW Carrie Henley	Last Updated: August 4, 2006
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Tom Bailey, MD - Family Medicine Carla J. Herman, MD, MPH - Internal Medicine
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.